Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. turned out to be negative for several others engaged in COVID-19 vaccine and treatment research. Pfizer announced Friday its oral COVID-19 pill Paxlovid reduced the risk of COVID-19-related…
The Week Ahead in Biotech (Nov. 7–Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs, and More
Cotton, Gallagher Urge Biden Administration to Blacklist Chinese Biotech Companies
Sen. Tom Cotton (R-Ark.), and Rep. Mike Gallagher (R-Wis.) on Sept. 30 called on the Biden administration to blacklist Chinese biotech companies, citing U.S. national security concerns, and the Chinese regime’s ambitions to “dominate biotechnology.” In a letter (pdf) to Treasury Secretary Janet Yellen, Commerce Secretary Gina Raimondo, and Defense Secretary Lloyd Austin, the Republican…
Stocks Are Up but Overall Outlook Is Far From Certain
Commentary The biggest news over the past week must include U.S. jobs growth. News of the nearly 1 million more jobs available in a month is certainly exceptional. Before 2020 when the United States achieved historically low unemployment rates, one-fourth or one-fifth of this was regarded as significant. The latest release called the Federal Reserve…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta